BENZENO SHARON bought ADPT
November 21, 2025 · Form 4 insider transaction
BENZENO SHARON bought 834 shares of Adaptive Biotechnologies Corporation at $6.27 per share, a transaction worth $5.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
834
Price
$6.27
Total value
$5.2K
InsiderBENZENO SHARON
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 21, 2025
Filing dateNovember 24, 2025
Shares owned after297,625
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025.